Clinical results of integrated therapy for moderate and severe intrauterine adhesion

ZHANG Luping; ZHAO Weihong; YANG Baojun; XU Yun; LI Wenjun; and FENG Limin

PDF(725 KB)

Medical Journal of the Chinese People Armed Police Forces ›› 2017, Vol. 28 ›› Issue (3) : 247-250.

ORIGINAL ARTICLES

Clinical results of integrated therapy for moderate and severe intrauterine adhesion

ZHANG Luping, ZHAO Weihong, YANG Baojun, XU Yun, LI Wenjun, and FENG Limin

Author information +

History +

Abstract

Objective To introduce an integrated therapy for women with moderate and severe intrauterine adhesion (IUA) and evaluate its reproductive outcome.Methods Seventy-five patients with IUA who had expected fertility and received an integrated therapy were retrospectively studied. The correlation of menstrual pattern, adhesion degree and adhesion reformation with the conception rate were analyzed.Results The mean age of these patients was (32.1±5.1) years old. The improvement rate of menstrual pattern was 78.7 %. The overall conception rate was 61.3 %. The conception rate was 76.6% for those with moderate IUA and 35.7% for severe cases of IUA (P<0.05). Logistic regression analysis showed that the preoperative adhesion degree and postoperative menstrual pattern were independent risk factors for pregnancy. The adhesion reformation rates during the second and third hysteroscopy were both 50%. There was significant difference in the adhesion reformation rate between moderate and severe cases of intrauterine adhesion(P<0.05). There were three (2.7%) cases of TURP syndrome during operation, which were quickly discovered and rescued.Conclusions The adhesion degree and menstrual pattern are independent risk factors for pregnancy, This integrated therapy can ensure better clinical effect for moderate and severe IUA patients, especially in restoring menstrual function and fertility.

Key words

intrauterine adhesion / asherman’s syndrome / hysteroscopy / adhesiolysis

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

ZHANG Luping, ZHAO Weihong, YANG Baojun, XU Yun, LI Wenjun, and FENG Limin. Clinical results of integrated therapy for moderate and severe intrauterine adhesion[J]. Medical Journal of the Chinese People Armed Police Forces. 2017, 28(3): 247-250

References

[1] Asherman J G. Traumatic intrauterine adhesions[J]. J Obstet Gynaecol Br Emp, 1950, 57: 892-896.
[2] March C M. Management of Asherman’s syndrome[J]. Reprod Biomed Online, 2011, 23(1): 63-76.
[3] The american fertility society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, mullerian anomalies and intrauterine adhesions[J]. Fertil Steril, 1988, 49(6): 944-955.
[4] 夏恩兰.妇科内镜学[M].北京:人民卫生出版社,2001:62.
[5] 彭雪冰,夏恩兰.羊膜宫腔内植入+人工周期治疗中、重度宫腔粘连的安全性及有效性[J].生殖与避孕,2012,32(12):857-861.
[6] Kodaman P H, Arici A. Intra-uterine adhesions and fertility outcome: how to optimize success? [J]. Curr Opin Obstet Gynecol, 2007, 19(3):207-214.
[7] Magos A. Hysteroscopic treatment of Asherman’s syndrome[J]. Reprod Biomed Online, 2002,3:46-51.
[8] Deans R, Abbott J. Review of intrauterine adhesions [J]. J Minim Invasive Gynecol, 2010,17(5):555-569.
[9] Zhang L,Xiong W,Xiong Y,et al.17 β-Estradiol promotes vascular endothelial growth factor expression via the Wnt/β-catenin pathway during the pathogenesis of endometriosis[J]. Mol Hum Reprod,2016,22(7):526-535.
[10] Mei J,Zhu X Y,Jin L P,et al. Estrogen promotes the survival of human secretory phase endometrial stromal cells via CXCL12/CXCR4 up-regulation-mediated autophagy inhibition[J]. Hum Reprod,2015, 30(7):1677-1689.
[11] Nayak N R, Brenner R M. Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium[J]. J Clin Endocrinol Metab, 2002, 87(4):1845-1855.
[12] Myers E M, Hurst B S. Comprehensive management of severe Asherman syndrome[J]. Fertil Steril, 2012, 97(1):160-164.
[13] Haapsamo M,Martikainen H, Rsnen J. Low-dose aspirin and uterine haemodynamics on the day of embryo transfer in women undergoing IVF/ICSI: a randomized, placebo-controlled, double-blind study[J]. Hum Reprod,2009, 24(4):861-866.
[14] Lebovitz O,Orvieto R. Treating patients with "thin" endometrium - an ongoing challenge[J]. Gynecol Endocrinol, 2014,30(6):409-414.
[15] Cicek N, Eryilmaz O G, Sarikaya E, et al.Vitamin E effect on controlled ovarian stimulation of unexplained infertile women[J].J Assist Reprod Genet, 2012, 29(4):325-328.
[16] Atilgan R, Kuloglu T, Ozkan Z S, et al. Evaluation of vitamin C and vitamin E for prevention of postoperative adhesion: a rat uterine horn model study[J]. J Obstet Gynaecol Res, 2015, 41(3):418-423.
[17] 郭佳,李东,刘承,等.补肾养血活血中药对超促排卵周期干预作用的随机对照研究[J].中国中西医结合杂志,2013,33(4):484-487.
[18] Preutthipan S, Linasmita V. Reproductive outcome following hysteroscopic lysis of intrauterine adhesions: a result of 65 cases at Ramathibodi Hospital[J]. J Med Assoc Thai, 2000, 83(1):42-46.
[19] Yu D, Li T C, Xia E, et al. Factors affecting reproductive outcome of hysteroscopic adhesiolysis for Asherman’s syndrome[J]. Fertil Steril, 2008, 89(3):715-722.
[20] AAGL Advancing Minimally Invasive Gynecology Worldwide. AAGL Practice Report: practice guidelines for management of intrauterine synechiae[J]. J Minim Invasive Gynecol, 2010, 17(1):1-7.
[21] Yang J H, Chen M J, Wu M Y, et al. Office hysteroscopic early lysis of intrauterine adhesion after transcervical resection of multiple apposing submucous myomas[J]. Fertil Steril, 2008,89(5):1254-1259.
[22] Robinson J K, Colimon L M, Isaacson K B. Postoperative adhesiolysis therapy for intrauterine adhesions (Asherman’s syndrome)[J]. Fertil Steril, 2008, 90(2):409-414.
[23] Tsui K H,Lin L T,Cheng J T,et al. Comprehensive treatment for infertile women with severe Asherman syndrome[J]. Taiwan J Obstet Gynecol,2014, 53(3):372-375.